We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$947M
AUM Growth
+$42.3M
Cap. Flow
-$10.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
37.5%
Holding
265
New
13
Increased
83
Reduced
137
Closed
13

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.48M
2
DHI icon
D.R. Horton
DHI
+$4.76M
3
CSCO icon
Cisco
CSCO
+$4.46M
4
STZ icon
Constellation Brands
STZ
+$4.2M
5
DGX icon
Quest Diagnostics
DGX
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 21.18%
2 Healthcare 10.11%
3 Financials 8.69%
4 Consumer Discretionary 6.97%
5 Industrials 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVSP icon
176
Univest Financial
UVSP
$1.23B
$488K 0.05%
26,967
+944
+4% +$18.5K
XLV icon
177
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$482K 0.05%
3,630
-6,929
-66% -$913K
DFAI
178
Dimensional International Core Equity Market ETF
DFAI
$17.2B
$482K 0.05%
+17,633
New +$483K
VEA icon
179
Vanguard FTSE Developed Markets ETF
VEA
$227B
$475K 0.05%
10,288
-5,201
-34% -$239K
IWP icon
180
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$452K 0.05%
4,676
-1,135
-20% -$103K
VNQ icon
181
Vanguard Real Estate ETF
VNQ
$39.8B
$439K 0.05%
5,251
-893
-15% -$73.2K
DUK icon
182
Duke Energy
DUK
$100B
$428K 0.05%
4,772
-311
-6% -$29.4K
IWV icon
183
iShares Russell 3000 ETF
IWV
$19.5B
$428K 0.05%
1,680
HYD icon
184
VanEck High Yield Muni ETF
HYD
$4.45B
$426K 0.05%
8,295
-330
-4% -$16.9K
PAYX icon
185
Paychex
PAYX
$41.1B
$422K 0.04%
3,775
-189
-5% -$20.7K
GIS icon
186
General Mills
GIS
$19.5B
$420K 0.04%
5,475
-1,176
-18% -$101K
IWO icon
187
iShares Russell 2000 Growth ETF
IWO
$14.4B
$415K 0.04%
1,711
-49
-3% -$11.2K
SO icon
188
Southern Company
SO
$109B
$409K 0.04%
5,824
-183
-3% -$13.1K
IQLT icon
189
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
$404K 0.04%
11,359
+291
+3% +$10.4K
CSX icon
190
CSX Corp
CSX
$96B
$390K 0.04%
11,434
-378
-3% -$12K
TRV icon
191
Travelers Companies
TRV
$81.4B
$387K 0.04%
2,227
-305
-12% -$53.8K
VOT icon
192
Vanguard Mid-Cap Growth ETF
VOT
$19.2B
$380K 0.04%
1,848
-93
-5% -$18K
IVW icon
193
iShares S&P 500 Growth ETF
IVW
$72.2B
$369K 0.04%
5,239
DFAX icon
194
Dimensional World ex US Core Equity 2 ETF
DFAX
$11.8B
$366K 0.04%
15,690
VO icon
195
Vanguard Mid-Cap ETF
VO
$107B
$364K 0.04%
6,612
-112
-2% -$5.87K
UAN icon
196
CVR Partners
UAN
$1.27B
$363K 0.04%
4,500
-2,500
-36% -$219K
CVS icon
197
CVS Health
CVS
$137B
$349K 0.04%
5,044
-2,762
-35% -$197K
HSY icon
198
Hershey
HSY
$36.6B
$349K 0.04%
1,396
DE icon
199
Deere & Co
DE
$169B
$343K 0.04%
847
+11
+1% +$4.21K
T icon
200
AT&T
T
$167B
$338K 0.04%
21,171
-674
-3% -$11.5K

Similar funds

Girard Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Girard Partners held 265 positions worth $947M, up 4.7% from $904M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Girard Partners's Q2 2023 filing shows 13 new, 83 increased, 137 reduced and 13 closed positions. Its largest new stake was Charles River Laboratories: 20,680 shares worth $4.35M. The largest sale was Amgen, an estimated $5.48M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Girard Partners's largest Q2 2023 buy was Charles River Laboratories: 20,680 shares worth $4.35M.
  • Girard Partners added most to Estee Lauder in Q2 2023, an estimated $3.62M increase.
  • Girard Partners's biggest Q2 2023 reduction was Amgen, cutting an estimated $5.48M.
  • Girard Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2023, selling an estimated $608K.
  • Girard Partners's ten largest holdings make up 37% of its $947M portfolio in Q2 2023.
  • Girard Partners opened 13 new positions and closed 13 in Q2 2023.
  • Girard Partners's portfolio value rose 4.7% quarter-over-quarter to $947M.

Based on Girard Partners's 13F filing for Q2 2023, filed 15 Aug 2023.